• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Qulipta Brand Team

anonymous

Guest
Please know that we are appreciative of what you do, we have an excellent medication and I personally think the commercials are outstanding. So take this in the spirit in which it is intended...

If you're going to send out a milestone congratulatory notice... just email it.

Taking the time to print a note, package it along with a tiny bag of bow-wraped gummy candies and then FedEx'ing it to everyone... what did that cost??? Save the money for the SPIFF contests please. But we do appreciate you.